2003
DOI: 10.1002/jcb.10597
|View full text |Cite
|
Sign up to set email alerts
|

Increased expression of Mcl‐1 is responsible for the blockage of TRAIL‐induced apoptosis mediated by EGF/ErbB1 signaling pathway

Abstract: Epidermal growth factor (EGF) protects against death receptor induced apoptosis in epithelial cells. Herein, we demonstrate that EGF protection against tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induced apoptosis is mediated by increased expression of the Bcl-2 family member myeloid cell leukemia 1 (Mcl-1). EGF increased the mRNA and protein levels of Mcl-1. Furthermore, expression of ErbB1 alone or in combination with ErbB2 in NIH3T3 cells up-regulates Mcl-1 following EGF treatment. In ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
56
0

Year Published

2004
2004
2012
2012

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(61 citation statements)
references
References 41 publications
5
56
0
Order By: Relevance
“…Therefore, our data show that P. aeruginosa mucoid strains, which chronically infect CF patients, do not elicit the expression of proinflammatory pathways in this model of airway epithelial cells. Interestingly, our microarray analysis showed FRD1-dependent up-regulation of genes with antiapoptotic effect on epithelial and other cell types (63)(64)(65), and exposure to an alginate-producing strain results in diminished apoptosis in Calu-3 airway epithelial cells. Thus, the lack of the appropriate host defense and inflammatory milieu in the airways, and impaired bacterial clearance because of reduced epithelial cell apoptosis (59,66), may explain the increased persistence of these strains in animal models of acute infection (15)(16)(17)(18).…”
Section: Discussionmentioning
confidence: 83%
“…Therefore, our data show that P. aeruginosa mucoid strains, which chronically infect CF patients, do not elicit the expression of proinflammatory pathways in this model of airway epithelial cells. Interestingly, our microarray analysis showed FRD1-dependent up-regulation of genes with antiapoptotic effect on epithelial and other cell types (63)(64)(65), and exposure to an alginate-producing strain results in diminished apoptosis in Calu-3 airway epithelial cells. Thus, the lack of the appropriate host defense and inflammatory milieu in the airways, and impaired bacterial clearance because of reduced epithelial cell apoptosis (59,66), may explain the increased persistence of these strains in animal models of acute infection (15)(16)(17)(18).…”
Section: Discussionmentioning
confidence: 83%
“…In zebrafish embryos, knockdown of zMcl1a and zMcl-1b substantially increased apoptosis triggered by ectopic expression of the Apo2L/TRAIL homolog zDL1b. Previous work suggests that in human hepatocellular carcinoma-derived cells, 32 human cholangiocarcinoma cells, 31 and NIH3T3 mouse fibroblasts, 30 Mcl-1 is a critical modulator of sensitivity to apoptosis signaling by Apo2L/TRAIL. Hence, endogenous Mcl-1 may be particularly important among prosurvival Bcl-2 family members in controlling apoptosis induction by stimuli that engage both the extrinsic and intrinsic apoptosis pathways.…”
Section: Discussionmentioning
confidence: 99%
“…[30][31][32] Thus, Mcl-1 may be a key modulator of DLinduced apoptosis in cells that require engagement of both the extrinsic and intrinsic pathways for commitment to apoptosis. Furthermore, these results indicate that endogenous zMcl-1a and zMcl-1b play an important role in curtailing apoptosis induction through the cell-intrinsic pathway in early zebrafish embryos.…”
Section: Apo2l/trailmentioning
confidence: 99%
“…41 There is mounting evidence that Mcl-1 may play an important role in regulating TRAIL-induced apoptosis in cancer cells by antagonizing proapoptotic Bcl-2 family members. [42][43][44][45][46] Furthermore, our findings demonstrate for the first time that neutralizing Mcl-1 is also an effective strategy to enhance the sensitivity of neuroblastoma cells to CD95-or chemotherapy-induced apoptosis. Thus, targeting the TRAIL/NF-jB/Mcl-1 axis in neuroblastoma cells, for example, by small molecule NF-jB inhibitors, may present a promising strategy to enhance the antitumor activity of TRAIL.…”
Section: Sensitization For Trail-induced Apoptosis By Nf-jb Inhibitionmentioning
confidence: 94%